Advanced Enzyme Technologies Ltd. Buyback (Advanced Enzyme Technologies Buyback 2026) Detail

Open Market Through Stock Exchange | ₹69.70 Crores | Listing at BSE, NSE | Fri, Aug 14, 2026 - Fri, Nov 20, 2026

Advanced Enzyme Technologies Ltd. Buyback is a Open Market Buyback for the repurchase of up to 0.14 crore equity shares, representing 1.24% of the total paid-up equity share capital at a buyback price of ₹500 per share with a face value of ₹2 per share, aggregating to ₹69.70 crores.

The buyback opens on Aug 14, 2026 and closes on Nov 20, 2026.

Emkay Global Financial Services Ltd. is the Manager to the Buyback, MUFG Intime India Pvt.Ltd. is the Registrar and Emkay Global Financial Services Ltd. is the Registered Broker to the Buyback.

Investors are advised to refer to the Advanced Enzyme Technologies Ltd. Letter of Offer for detailed information, including eligibility criteria, entitlement ratio, acceptance methodology, and tax implications.

Buyback Stock Quote & Charts

Advanced Enzyme Technologies Buyback 2026 Detail

Issue Type

Open Market Through Stock Exchange
Buyback Price

₹500 per share
Listing at

BSE, NSE

Issue Size (Amount)

₹69.70 Crores
Face Value

₹2 per share

Company Financials (Restated)

Advanced Enzyme Technologies Ltd.’s revenue increased by 17% and profit after tax (PAT) rose by 30% between the financial year ending with March 31, 2026 and March 31, 2025. (Amount in ₹ Crore)

Period Ended	31 Mar 2026	31 Mar 2025
Assets	1,838.76	1,621.35
Total Income	780.59	669.95
Profit After Tax	173.61	133.97

About Advanced Enzyme Technologies Ltd.

Incorporated in 1989, Advanced Enzyme Technologies Limited is a research-driven biotechnology company engaged in developing, manufacturing and marketing enzymes and probiotics for diverse industries.

The company offers enzyme-based solutions across human and animal nutrition, food processing, pharmaceuticals, textiles, leather, paper and pulp, biofuels, and other industrial applications.

Advanced Enzyme Technologies has expanded internationally and serves hundreds of customers across multiple countries, supported by manufacturing and R&D capabilities in India and overseas.

Necessity of the Issue

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:

Return surplus funds to shareholders and enhance overall shareholder returns.
Improve financial ratios such as earnings per share and return on equity.
Enhance long-term shareholder value.
Provide shareholders the flexibility to either participate in the Buyback for cash or retain their shareholding and benefit from an increased post-buyback ownership.

Company Contact Information

Advanced Enzyme Technologies Ltd.
5th Floor, ‘A’ wing
Sun Magnetica
LIC Service Road, Louiswadi,
Thane, Maharashtra, 400604

+91-22-4170 3200
info@advancedenzymes.com
Visit Website

Buyback Registrar

MUFG Intime India Pvt.Ltd.

022-49186000
investor.helpdesk@in.mpms.mufg.com
Visit Website

Advanced Enzyme Technologies Buyback 2026 Manager

Lead Manager(s)

Emkay Global Financial Services Ltd.

Registered Broker

Emkay Global Financial Services Ltd.

Find Advanced Enzyme Technologies Buyback 2026 Latest Update

Advanced Enzyme Technologies Buyback 2026 FAQs
Advanced Enzyme Technologies Buyback 2026 Live News

IPO FAQs

When is Advanced Enzyme Technologies Buyback 2026 offer coming?

The Advanced Enzyme Technologies Buyback 2026 opens on August 14, 2026, and closes on November 20, 2026.

Which type of buyback is Advanced Enzyme Technologies Buyback 2026 offering?

The Advanced Enzyme Technologies Buyback 2026 is a Open Market Through Stock Exchange.

What is the schedule of activities for Advanced Enzyme Technologies Buyback 2026?

Advanced Enzyme Technologies Buyback 2026 Schedule

Buyback Opening Date	August 14, 2026
Buyback Closing Date	November 20, 2026
Last date for acceptance of shares	Upon relevant pay-out by the Stock exchange

What is the offer price for Advanced Enzyme Technologies Buyback 2026 offer?

The Advanced Enzyme Technologies Buyback 2026 is being offered at Rs ₹500 per share.

In what ratio is the Advanced Enzyme Technologies Buyback 2026 offered?

There is no ratio applicable in case of open market offer through stock exchange mechanism.

What is the record date for Advanced Enzyme Technologies Buyback 2026 offer?

There is no concept of record date in case of open market offer through stock exchange mechanism.

What is the issue size of Advanced Enzyme Technologies Buyback 2026?

The Advanced Enzyme Technologies Buyback 2026 has announced a buyback for an aggregate amount of not more than Rs. ₹69.70 Crores with pricing of Rs. ₹500 per share.

What is the necessity for Advanced Enzyme Technologies Buyback 2026?

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:

Return surplus funds to shareholders and enhance overall shareholder returns.
Improve financial ratios such as earnings per share and return on equity.
Enhance long-term shareholder value.
Provide shareholders the flexibility to either participate in the Buyback for cash or retain their shareholding and benefit from an increased post-buyback ownership.

Where can I get the Public Announcement for Advanced Enzyme Technologies Buyback 2026?

Public Announcement

How to participate in Advanced Enzyme Technologies Buyback 2026?

Any equity shareholder holding the shares in Demat form can participate in the buyback offer through their stockbroker. The physical shareholder can participate only once the shares get converted into a Dematerialized form.

The shareholder needs to inform their broker on the details of the Equity shares they wish to sell. The broker will place a sell order whenever the company places a buy order for the buyback. The trade would get executed at the offer price or lesser only when the price offered by the shareholder matches with the buy order placed by the company.

Is Advanced Enzyme Technologies Buyback 2026 good or bad?

The Advanced Enzyme Technologies Buyback 2026 offers an opportunity for the shareholders to exit their positions at a premium price. In case you stay invested you would have an increased percentage of shareholding in the company and improved earnings per share. Thus, one should understand the company fundamentals along with one’s need, goals, and risk appetite to decide if one wants to stay invested or participate in the buyback offer.